1Department of Pharmacology and Therapeutics, State University of Maringá, Brazil.
J Psychopharmacol. 2013 Dec;27(12):1141-8. doi: 10.1177/0269881113485144. Epub 2013 Apr 17.
Previous results with the elevated T-maze (ETM) test indicate that the antipanic action of serotonin (5-HT) in the dorsal periaqueductal grey (dPAG) depends on the activation endogenous opioid peptides. The aim of the present work was to investigate the interaction between opioid- and serotonin-mediated neurotransmission in the modulation of defensive responses in rats submitted to the ETM. The obtained results showed that intra-dPAG administration of morphine significantly increased escape latency, a panicolytic-like effect that was blocked by pre-treatment with intra-dPAG injection of either naloxone or the 5-HT1A antagonist N-[2-[4-(2-methoxyphenyl)-1 piperazinyl] ethyl] -N- 2- pyridinyl-ciclohexanecarboxamide maleate (WAY-100635). In addition, previous administration of naloxone antagonized both the anti-escape and the anti-avoidance (anxiolytic-like) effect of the 5-HT1A agonist (±)-8-hydroxy-2-(di-n-propylamino)tetralin hydrobromide (8-OH-DPAT), but did not affect the anti-escape effect of the 5-HT2A agonist (±)-2,5-dimethoxy-4-iodoamphetamine hydrochloride (DOI). Moreover, the combination of sub-effective doses of locally administered 5-HT and morphine significantly impaired ETM escape performance. Finally, the µ-antagonist D-PHE-CYS-TYR-D-TRP-ORN-THR-PEN (CTOP) blocked the anti-avoidance as well as the anti-escape effect of 8-OHDPAT, and the association of sub-effective doses of the µ-opioid receptor agonist [D-Ala(2), N-Me-Phe(4), Gly(5)-ol]-enkephalin acetate salt (DAMGO) and of 8-OHDPAT had anti-escape and anti-avoidance effects in the ETM. These results suggest a synergic interaction between the 5-HT1A and the µ-opioid receptor at post-synaptic level on neurons of the dPAG that regulate proximal defense, theoretically related to panic attacks.
先前的高架十字迷宫(ETM)测试结果表明,5-羟色胺(5-HT)在背侧periaqueductal 灰色(dPAG)中的抗惊恐作用取决于内源性阿片肽的激活。本工作的目的是研究阿片肽和 5-HT 介导的神经递质传递之间的相互作用,以调节接受 ETM 的大鼠的防御反应。所得结果表明,脑室内给予吗啡可显著增加逃避潜伏期,表现出类似惊恐的作用,而该作用可被脑室内预先给予纳洛酮或 5-HT1A 拮抗剂 N-[2-[4-(2-甲氧基苯基)-1 哌嗪基]乙基]-N-2-吡啶基环已烷甲酰胺马来酸盐(WAY-100635)所阻断。此外,预先给予纳洛酮拮抗 5-HT1A 激动剂(±)-8-羟基-2-(二正丙基氨基)四氢萘盐酸盐(8-OH-DPAT)的抗逃避和抗回避(抗焦虑样)作用,但不影响 5-HT2A 激动剂(±)-2,5-二甲氧基-4-碘苯丙胺盐酸盐(DOI)的抗逃避作用。此外,局部给予低剂量的 5-HT 和吗啡联合显著损害 ETM 逃避性能。最后,µ 拮抗剂 D-PHE-CYS-TYR-D-TRP-ORN-THR-PEN(CTOP)阻断了 8-OHDPAT 的抗回避和抗逃避作用,而低剂量µ-阿片受体激动剂[D-Ala(2),N-Me-Phe(4),Gly(5)-ol]-脑啡肽醋酸盐盐(DAMGO)和 8-OHDPAT 的联合对 ETM 具有抗逃避和抗回避作用。这些结果表明,5-HT1A 和 µ-阿片受体在调节近端防御的神经元上在后突触水平上存在协同相互作用,这与惊恐发作理论上有关。